Be it a temporary illness or chronic disease, women’s health issues deserve more attention, especially in under-developed regions where there is lack of proper healthcare facilities. Women undergo a lot of life changing phases during their lifetime that hamper their physical, as well as psychological, health. Such changes can potentially affect overall health of women causing various minor or major ailments. Some of the common health issues faced by women include Polycystic Ovary Syndrome (PCOS), endometriosis, and postmenopausal osteoporosis among others.
Postmenopausal Osteoporosis to Emerge Dominant
Infertility, PCOS, menopause, endometriosis, postmenopausal osteoporosis, and contraceptives are the major application areas for women’s healthcare. Postmenopausal osteoporosis witnessed the highest application due to the presence of a large number of women with postmenopausal osteoporosis and easy availability of cost-effective treatments. In addition, rising number of ongoing research and development is predicted to boost demand from this sector in near future. In the recent past, the U.S. Food & Drug Administration (FDA) approved Radius Health’s TYMLOS (abaloparatide), a bone building agent for the treatment of postmenopausal osteoporosis. The newly approved injection reduces risks of nonvertebral and vertebral fractures.
Contraceptives are anticipated to witness the fastest growth in the forthcoming years. This rapid rise in demand is attributed to constant innovation in terms of novel and highly developed contraceptive methods and rising awareness regarding family planning. Furthermore, supportive government rules and regulations in developed regions such as United States along with awareness regarding the availability of various contraceptive methods are also likely to augment demand.
Market Overview
Based on the findings of a report published by Grand View Research, Inc.; the global women’s health market was estimated at USD 36.5 billion in 2016. It is expected to reach a valuation of around USD 51.3 billion by 2025. The global market is predicted to register a healthy CAGR of around 3.9% during the forecast years (2018 to 2025). Key factors driving this market include rising female population, supportive government policies, and introduction of novel drugs for women. Pfizer, Inc.; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd.; Ferring B.V.; and Agile Therapeutics, Inc. are some of the prominent global market players.
In-Depth Research Report On Women’s Health Market:
https://www.grandviewresearch.com/industry-analysis/womens-health-market
No comments:
Post a Comment